Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 138

1.

Retroperitoneal Lymph Node Dissection as Primary Treatment for Men With Testicular Seminoma: Utilization and Survival Analysis Using the National Cancer Data Base, 2004-2014.

Tabakin AL, Shinder BM, Kim S, Rivera-Nunez Z, Polotti CF, Modi PK, Sterling JA, Farber NJ, Radadia KD, Parikh RR, Kim IY, Saraiya B, Mayer TM, Singer EA, Jang TL.

Clin Genitourin Cancer. 2019 Nov 6. pii: S1558-7673(19)30322-2. doi: 10.1016/j.clgc.2019.10.018. [Epub ahead of print]

PMID:
31818649
2.

Cytoreductive prostatectomy in metastatic prostate cancer: current knowledge and future directions.

Polotti CF, Sterling JA, Kim IY.

Am J Clin Exp Urol. 2019 Apr 25;7(2):80-84. eCollection 2019. Review.

3.

Platelet-derived β2M regulates monocyte inflammatory responses.

Hilt ZT, Pariser DN, Ture SK, Mohan A, Quijada P, Asante AA, Cameron SJ, Sterling JA, Merkel AR, Johanson AL, Jenkins JL, Small EM, McGrath KE, Palis J, Elliott MR, Morrell CN.

JCI Insight. 2019 Mar 7;4(5). pii: 122943. doi: 10.1172/jci.insight.122943. eCollection 2019 Mar 7.

4.

β2ARs stimulation in osteoblasts promotes breast cancer cell adhesion to bone marrow endothelial cells in an IL-1β and selectin-dependent manner.

Clément-Demange L, Mulcrone PL, Tabarestani TQ, Sterling JA, Elefteriou F.

J Bone Oncol. 2018 Sep 8;13:1-10. doi: 10.1016/j.jbo.2018.09.002. eCollection 2018 Nov.

5.

Settable polymer/ceramic composite bone grafts stabilize weight-bearing tibial plateau slot defects and integrate with host bone in an ovine model.

Lu S, McGough MAP, Shiels SM, Zienkiewicz KJ, Merkel AR, Vanderburgh JP, Nyman JS, Sterling JA, Tennent DJ, Wenke JC, Guelcher SA.

Biomaterials. 2018 Oct;179:29-45. doi: 10.1016/j.biomaterials.2018.06.032. Epub 2018 Jun 26.

6.

Early TGF-β inhibition in mice reduces the incidence of breast cancer induced bone disease in a myeloid dependent manner.

Buenrostro D, Kwakwa KA, Putnam NE, Merkel AR, Johnson JR, Cassat JE, Sterling JA.

Bone. 2018 Aug;113:77-88. doi: 10.1016/j.bone.2018.05.008. Epub 2018 May 16.

7.

3D bone models to study the complex physical and cellular interactions between tumor and the bone microenvironment.

Vanderburgh JP, Guelcher SA, Sterling JA.

J Cell Biochem. 2018 Jul;119(7):5053-5059. doi: 10.1002/jcb.26774. Epub 2018 Mar 30.

PMID:
29600556
8.

Fabrication of Trabecular Bone-Templated Tissue-Engineered Constructs by 3D Inkjet Printing.

Vanderburgh JP, Fernando SJ, Merkel AR, Sterling JA, Guelcher SA.

Adv Healthc Mater. 2017 Nov;6(22). doi: 10.1002/adhm.201700369. Epub 2017 Sep 11.

9.

Integrin αvβ3 Signaling in Tumor-Induced Bone Disease.

Kwakwa KA, Sterling JA.

Cancers (Basel). 2017 Jul 8;9(7). pii: E84. doi: 10.3390/cancers9070084. Review.

10.

Engineering 3D Models of Tumors and Bone to Understand Tumor-Induced Bone Disease and Improve Treatments.

Kwakwa KA, Vanderburgh JP, Guelcher SA, Sterling JA.

Curr Osteoporos Rep. 2017 Aug;15(4):247-254. doi: 10.1007/s11914-017-0385-9. Review.

11.

Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch.

Mulcrone PL, Campbell JP, Clément-Demange L, Anbinder AL, Merkel AR, Brekken RA, Sterling JA, Elefteriou F.

J Bone Miner Res. 2017 Jul;32(7):1442-1454. doi: 10.1002/jbmr.3133. Epub 2017 Apr 28.

12.

Murine models of breast cancer bone metastasis.

Wright LE, Ottewell PD, Rucci N, Peyruchaud O, Pagnotti GM, Chiechi A, Buijs JT, Sterling JA.

Bonekey Rep. 2016 May 11;5:804. eCollection 2016.

13.

Erratum: Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.

Johnson RW, Finger EC, Olcina MM, Vilalta M, Aguilera T, Miao Y, Merkel AR, Johnson JR, Sterling JA, Wu JY, Giaccia AJ.

Nat Cell Biol. 2016 Oct 27;18(11):1260. doi: 10.1038/ncb3433.

PMID:
27784904
14.

Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma.

Cannonier SA, Gonzales CB, Ely K, Guelcher SA, Sterling JA.

Oncotarget. 2016 Nov 15;7(46):76062-76075. doi: 10.18632/oncotarget.12584.

15.

Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.

Johnson RW, Finger EC, Olcina MM, Vilalta M, Aguilera T, Miao Y, Merkel AR, Johnson JR, Sterling JA, Wu JY, Giaccia AJ.

Nat Cell Biol. 2016 Oct;18(10):1078-1089. doi: 10.1038/ncb3408. Epub 2016 Sep 19. Erratum in: Nat Cell Biol. 2016 Oct 27;18(11):1260.

16.

Substrate Modulus Regulates Osteogenic Differentiation of Rat Mesenchymal Stem Cells through Integrin β1 and BMP Receptor Type IA.

Guo R, Lu S, Merkel AR, Sterling JA, Guelcher SA.

J Mater Chem B. 2016 May 28;4(20):3584-3593. Epub 2016 Apr 1.

17.

Combined treatment with a transforming growth factor beta inhibitor (1D11) and bortezomib improves bone architecture in a mouse model of myeloma-induced bone disease.

Nyman JS, Merkel AR, Uppuganti S, Nayak B, Rowland B, Makowski AJ, Oyajobi BO, Sterling JA.

Bone. 2016 Oct;91:81-91. doi: 10.1016/j.bone.2016.07.007. Epub 2016 Jul 14.

18.

The Bone Microenvironment: a Fertile Soil for Tumor Growth.

Buenrostro D, Mulcrone PL, Owens P, Sterling JA.

Curr Osteoporos Rep. 2016 Aug;14(4):151-8. doi: 10.1007/s11914-016-0315-2. Review.

19.

3D Printing of Tissue Engineered Constructs for In Vitro Modeling of Disease Progression and Drug Screening.

Vanderburgh J, Sterling JA, Guelcher SA.

Ann Biomed Eng. 2017 Jan;45(1):164-179. doi: 10.1007/s10439-016-1640-4. Epub 2016 May 11. Review.

20.

Substrate modulus of 3D-printed scaffolds regulates the regenerative response in subcutaneous implants through the macrophage phenotype and Wnt signaling.

Guo R, Merkel AR, Sterling JA, Davidson JM, Guelcher SA.

Biomaterials. 2015 Dec;73:85-95. doi: 10.1016/j.biomaterials.2015.09.005. Epub 2015 Sep 11.

21.

The Role of Hedgehog Signaling in Tumor Induced Bone Disease.

Cannonier SA, Sterling JA.

Cancers (Basel). 2015 Aug 26;7(3):1658-83. doi: 10.3390/cancers7030856. Review.

22.

Altering adsorbed proteins or cellular gene expression in bone-metastatic cancer cells affects PTHrP and Gli2 without altering cell growth.

Page JM, Merkel AR, Ruppender NS, Guo R, Dadwal UC, Cannonier S, Basu S, Guelcher SA, Sterling JA.

Data Brief. 2015 Jul 13;4:440-6. doi: 10.1016/j.dib.2015.07.003. eCollection 2015 Sep.

23.

Fabrication of 3D Scaffolds with Precisely Controlled Substrate Modulus and Pore Size by Templated-Fused Deposition Modeling to Direct Osteogenic Differentiation.

Guo R, Lu S, Page JM, Merkel AR, Basu S, Sterling JA, Guelcher SA.

Adv Healthc Mater. 2015 Aug 26;4(12):1826-32. doi: 10.1002/adhm.201500099. Epub 2015 Jun 29.

24.

Matrix rigidity regulates the transition of tumor cells to a bone-destructive phenotype through integrin β3 and TGF-β receptor type II.

Page JM, Merkel AR, Ruppender NS, Guo R, Dadwal UC, Cannonier S, Basu S, Guelcher SA, Sterling JA.

Biomaterials. 2015 Sep;64:33-44. doi: 10.1016/j.biomaterials.2015.06.026. Epub 2015 Jun 16.

25.

Predicting mouse vertebra strength with micro-computed tomography-derived finite element analysis.

Nyman JS, Uppuganti S, Makowski AJ, Rowland BJ, Merkel AR, Sterling JA, Bredbenner TL, Perrien DS.

Bonekey Rep. 2015 Apr 22;4:664. doi: 10.1038/bonekey.2015.31. eCollection 2015.

26.

Addressing the controversy: do bisphosphonates directly affect primary tumors?

Sterling JA.

Cancer Discov. 2015 Jan;5(1):14-5. doi: 10.1158/2159-8290.CD-14-1380.

27.

Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.

Johnson RW, Merkel AR, Page JM, Ruppender NS, Guelcher SA, Sterling JA.

Clin Exp Metastasis. 2014 Dec;31(8):945-59. doi: 10.1007/s10585-014-9682-1. Epub 2014 Oct 31.

28.

Dissecting the role of bone marrow stromal cells on bone metastases.

Buenrostro D, Park SI, Sterling JA.

Biomed Res Int. 2014;2014:875305. doi: 10.1155/2014/875305. Epub 2014 Jun 26. Review.

29.

Development of Raman spectral markers to assess metastatic bone in breast cancer.

Ding H, Nyman JS, Sterling JA, Perrien DS, Mahadevan-Jansen A, Bi X.

J Biomed Opt. 2014;19(11):111606. doi: 10.1117/1.JBO.19.11.111606.

30.

Co-registration of multi-modality imaging allows for comprehensive analysis of tumor-induced bone disease.

Seeley EH, Wilson KJ, Yankeelov TE, Johnson RW, Gore JC, Caprioli RM, Matrisian LM, Sterling JA.

Bone. 2014 Apr;61:208-16. doi: 10.1016/j.bone.2014.01.017. Epub 2014 Jan 30.

31.

Biomaterial scaffolds for treating osteoporotic bone.

Sterling JA, Guelcher SA.

Curr Osteoporos Rep. 2014 Mar;12(1):48-54. doi: 10.1007/s11914-014-0187-2. Review.

32.

ALCAM/CD166 is a TGF-β-responsive marker and functional regulator of prostate cancer metastasis to bone.

Hansen AG, Arnold SA, Jiang M, Palmer TD, Ketova T, Merkel A, Pickup M, Samaras S, Shyr Y, Moses HL, Hayward SW, Sterling JA, Zijlstra A.

Cancer Res. 2014 Mar 1;74(5):1404-15. doi: 10.1158/0008-5472.CAN-13-1296. Epub 2014 Jan 2.

33.

Prostate cancer metastases alter bone mineral and matrix composition independent of effects on bone architecture in mice--a quantitative study using microCT and Raman spectroscopy.

Bi X, Sterling JA, Merkel AR, Perrien DS, Nyman JS, Mahadevan-Jansen A.

Bone. 2013 Oct;56(2):454-60. doi: 10.1016/j.bone.2013.07.006. Epub 2013 Jul 15.

34.

Activation of NF-kappa B signaling promotes growth of prostate cancer cells in bone.

Jin R, Sterling JA, Edwards JR, DeGraff DJ, Lee C, Park SI, Matusik RJ.

PLoS One. 2013;8(4):e60983. doi: 10.1371/journal.pone.0060983. Epub 2013 Apr 5.

35.

Myeloid-derived suppressor cells expand during breast cancer progression and promote tumor-induced bone destruction.

Danilin S, Merkel AR, Johnson JR, Johnson RW, Edwards JR, Sterling JA.

Oncoimmunology. 2012 Dec 1;1(9):1484-1494.

36.

Models of bone metastasis.

Campbell JP, Merkel AR, Masood-Campbell SK, Elefteriou F, Sterling JA.

J Vis Exp. 2012 Sep 4;(67):e4260. doi: 10.3791/4260.

37.

Stimulation of host bone marrow stromal cells by sympathetic nerves promotes breast cancer bone metastasis in mice.

Campbell JP, Karolak MR, Ma Y, Perrien DS, Masood-Campbell SK, Penner NL, Munoz SA, Zijlstra A, Yang X, Sterling JA, Elefteriou F.

PLoS Biol. 2012 Jul;10(7):e1001363. doi: 10.1371/journal.pbio.1001363. Epub 2012 Jul 17.

38.

Loss of TGF-β responsiveness in prostate stromal cells alters chemokine levels and facilitates the development of mixed osteoblastic/osteolytic bone lesions.

Li X, Sterling JA, Fan KH, Vessella RL, Shyr Y, Hayward SW, Matrisian LM, Bhowmick NA.

Mol Cancer Res. 2012 Apr;10(4):494-503. doi: 10.1158/1541-7786.MCR-11-0506. Epub 2012 Jan 30.

39.

6-Thioguanine inhibition of parathyroid hormone-related protein expression is mediated by GLI2.

Johnson RW, Merkel AR, Danilin S, Nguyen MP, Mundy GR, Sterling JA.

Anticancer Res. 2011 Sep;31(9):2705-12.

40.

Contribution of bone tissue modulus to breast cancer metastasis to bone.

Guelcher SA, Sterling JA.

Cancer Microenviron. 2011 Dec;4(3):247-59. doi: 10.1007/s12307-011-0078-3. Epub 2011 Jul 26.

41.

Bone structural components regulating sites of tumor metastasis.

Sterling JA, Guelcher SA.

Curr Osteoporos Rep. 2011 Jun;9(2):89-95. doi: 10.1007/s11914-011-0052-5. Review.

42.

TGF-beta promotion of Gli2-induced expression of parathyroid hormone-related protein, an important osteolytic factor in bone metastasis, is independent of canonical Hedgehog signaling.

Johnson RW, Nguyen MP, Padalecki SS, Grubbs BG, Merkel AR, Oyajobi BO, Matrisian LM, Mundy GR, Sterling JA.

Cancer Res. 2011 Feb 1;71(3):822-31. doi: 10.1158/0008-5472.CAN-10-2993. Epub 2010 Dec 28.

43.

Matrix rigidity induces osteolytic gene expression of metastatic breast cancer cells.

Ruppender NS, Merkel AR, Martin TJ, Mundy GR, Sterling JA, Guelcher SA.

PLoS One. 2010 Nov 15;5(11):e15451. doi: 10.1371/journal.pone.0015451.

44.

Longitudinal live animal micro-CT allows for quantitative analysis of tumor-induced bone destruction.

Johnson LC, Johnson RW, Munoz SA, Mundy GR, Peterson TE, Sterling JA.

Bone. 2011 Jan;48(1):141-51. doi: 10.1016/j.bone.2010.05.033. Epub 2010 Jun 1.

45.

Advances in the biology of bone metastasis: how the skeleton affects tumor behavior.

Sterling JA, Edwards JR, Martin TJ, Mundy GR.

Bone. 2011 Jan;48(1):6-15. doi: 10.1016/j.bone.2010.07.015. Epub 2010 Jul 17. Review.

PMID:
20643235
46.

The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.

Sterling JA, Oyajobi BO, Grubbs B, Padalecki SS, Munoz SA, Gupta A, Story B, Zhao M, Mundy GR.

Cancer Res. 2006 Aug 1;66(15):7548-53.

47.

PARP regulates TGF-beta receptor type II expression in estrogen receptor-positive breast cancer cell lines.

Sterling JA, Wu L, Banerji SS.

Anticancer Res. 2006 May-Jun;26(3A):1893-901.

48.

The relationship between central corneal thickness-adjusted intraocular pressure and glaucomatous visual-field loss.

Sullivan-Mee M, Halverson KD, Saxon GB, Saxon MC, Shafer KM, Sterling JA, Sterling MJ, Qualls C.

Optometry. 2005 Apr;76(4):228-38.

PMID:
15832843
49.

American milk mama.

Midgarden A, Sterling JA.

J Christ Nurs. 1996 Winter;13(1):28-30. No abstract available.

PMID:
9362785
50.

Nasal airway positive pressure in patients with occlusive sleep apnea. Methods and feasibility.

Remmers JE, Sterling JA, Thorarinsson B, Kuna ST.

Am Rev Respir Dis. 1984 Dec;130(6):1152-5.

PMID:
6391309

Supplemental Content

Loading ...
Support Center